Oral ulcers;Úlceras orales

Medicina Clinica

Volumn 125, Issue 15, 2005, Pages 590-597

  Bascones Martínez, Antonio ^a   Figuero Ruiz, Elena ^a   Esparza Gómez, Germán Carlos ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Aphthous stomatitis; Benign mucous membrane pemphigoid; Necrotizing sialometaplasia; Necrotizing ulcerative gingivitis; Oral cancer; Oral lichen planus; Oral ulcer; Pemphigus

Indexed keywords

ALENDRONIC ACID; ALPRAZOLAM; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CAPTOPRIL; CHLORPROMAZINE; CLONAZEPAM; CYCLOSPORIN; DILTIAZEM; DISOPYRAMIDE; ENALAPRIL; FLUOXETINE; HYDRALAZINE; IMIPRAMINE; LAMOTRIGINE; NEUROLEPTIC AGENT; NIFEDIPINE; OLANZAPINE; PHENYTOIN; PROPRANOLOL DERIVATIVE; QUINIDINE; TERBUTALINE; UNINDEXED DRUG; VENLAFAXINE; WARFARIN;

ACUTE DISEASE; APHTHOUS STOMATITIS; BACTERIAL INFECTION; BULLOUS SKIN DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HUMAN; INJURY; LICHEN PLANUS; MOUTH CARCINOMA; MOUTH CAVITY; MOUTH DISEASE; MOUTH ULCER; PAIN; PATHOLOGY; PEMPHIGUS; RECURRENT DISEASE; REVIEW; SALIVARY GLAND DISEASE; TREATMENT PLANNING; VIRUS INFECTION;

ACUTE DISEASE; CHRONIC DISEASE; HUMANS; ORAL ULCER;

EID: 28444441984     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13080655     Document Type: Review

References (81)

1. a ed. Barcelona: Ariel y Ediciones Avances; 2004.
2. Bruce AJ, Rogers RS. Acute oral ulcers. Dermatol Clin. 2003;21:1-15.
3. Esparza, GC, Llamas S, Bascones A. Lesiones con pérdida de sustancia: úlceras. En: Bascones Martínez A, editor. Estomatología. Tratado de medicina interna. Barcelona: Ariel. 2005. En prensa.
4. Razmus TF. Tongue ulcerated by trauma: report of a case. JADA. 1992;123:82-6.
5. Murdoch-Kinch CA, Miles DA. Oral mucosal injury caused by denture cleanser tablets. A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:756-8.
6. Shimoyama T, Kaneko T, Nasu D, Suzuki T, Horie N. A case of an electrical burn in the oral cavity of an adult. J oral Sci. 1999;41:127-8.
7. Nahlieli O, Eliav E, Shapira Y, Baruchin AM. Central palatal burns associated with the eating of microwaved pizzas. Burns. 1999;25:465-6.
8. Esparza Gómez GC, López-Argüello Illana C, García Núñez JA, Moreno López LA. Estomatitis aftosa recidivante. Revisión y puesta al día. Med Oral. 1998;3:18-35.
9. Esparza Gómez GC, Cerero Lapiedra R, Moreno López LA. Estomatitis aftosa recurrente. Gaceta Dental. 2000;104:44-52.
10. Shulman JD. An extrapolation of point, annual, and lifetime prevalence in characterizing recurrent aphthous stomatitis in USA children and youths. J Oral Pathol Med. 2004;33:558-66.
11. Natah SS, Konttinen YT, Enattah NS, Ashammakhi N, Sharkey KA, Häyrinen-Immonen R. Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg. 2004;33:221-34.
12. Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M. Recurrent aphthous stomatitis. Quintessence Int. 2000;31:95-112.
13. Rogers RS. Recurrent aphthous stomatitis in the diagnosis of Behçet's disease. Yonsei Med J. 1997;38:370-9.
14. Akpolat T. Management of the patient with Behçet's disease. Nephrol Dial Transplant. 1998;13:3002-4.
15. De Alburquerque PR, Terreri MTRA, Len C, Hilario MOE. Behçet's disease in childhood. J Pediatr (Rio J). 2002;78:128-32.
16. Cheng YK, Thong BY, Chng HH. Behçet's disease: experience in a tertiary rheumatology centre in Singapore and a review of the literature. Ann Acad Med Singapore. 2004;33:510-4.
17. Gertner E. Severe recurrent neurological diseases in the MAGIC syndrome. J Rheumatol. 2004;31:1018-9.
18. Femiano F, Gombos F, Scully C. Sweet's syndrome: recurrent oral ulceration, pyrexia, thrombophlebitis and cutaneous lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:324-7.
19. Sun A, Hsieh R, Chu C, Wang J, Liu B, Chiang C. Some specific human leukocyte antigen (HLA)-DCVDR haplotypes are more important than individual HLA-DR and -DQ phenotypes for the development of mucocutaneous type of Behçet's disease and for disease shift from recurrent aphthous stomatitis to mucocutaneous type of Behçet's disease. J Oral Pathol Med. 2001;30:402-7.
20. Riggio MP, Lennon A, Ghodratnama F, Wray D. Lack of association between Streptococcus oralis and recurrent aphthous stomatitis. J Oral Pathol Med. 2000;29:26-32.
21. Riggio M, Lennon A, Wray D. Detection of Helicobacter pylori DNA in recurrent aphthous stomatitis tissue by PCR. J Oral Pathol Med. 2000;29:507-13.
22. Shimoyama T, Horie N, Kaneko T, Komiyama K. Helicobacter pylori in oral ulcerations. J Oral Sci. 2000;42:225-9.
23. Victoria JM, Kalapothakis E, Silva J, Gómez RS. Helicobacter pylori DNA in recurrent aphthous stomatitis. J Oral Pathol Med. 2003;32:219-23.
24. Fristscher AMG, Cherubini K, Chies J, Dias AGO. Association between Helicobacter pylori and recurrent aphthous stomatitis in children and adolescents. J Oral Pathol Med. 2004;33:129-32.
25. Brice S, Cook D, Leahy M, Huff C. Examination of the oral mucosa and peripheral blood cells of patients with recurrent aphthous ulceration for human herpes virus DNA. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89:193-8.
26. Ghodratnama F, Rigio MP, Wray D. Search for human herpes virus 6, human cytomegalovirus and varicella zoster virus DNA in recurrent aphthous stomatitis tissue. J Oral Pathol Med. 1997;26:192-7.
27. Ghodratnama F, Wray D, Bagg J. Detection of serum antibodies against cytomegalovirus, varicella zoster virus and human herpes virus 6 in patients with recurrent oral ulceration. J Oral Pathol Med. 1999;28:12-5.
28. Sun A, Chang JG, Chu CT, Yuan JH, Chiang CP. Preliminary evidence for an association of Epstein-Barr virus with pre-ulcerative oral lesions in patients with recurrent aphthous ulcers or Behçet's disease. J Oral Pathol Med. 1998;27:168-75.
29. Healy CM, Haskard DO, Thornhill MH. Raised levels of circulating VCAM-1 and circulating E-selectin in patients with recurrent oral ulceration. J Oral Pathol Med. 1997;26:23-8.
30. Healy CM, Thornhill MH. Induction of adhesion molecule expression on blood vessels and keratinocytes in recurrent oral ulceration. J Oral Pathol Med. 1999;28:5-11.
31. Natah S, Hayrinen-Immonen R, Hietanen J, Malmström M, Konttinen Y. Immunolocalization of tumor necrosis factor-α expressing cells in recurrent aphthous ulcers (RAU). J Oral Pathol Med. 2000;29:19-25.
32. Atkin PA, Xu X, Thornhill MH. Minor recurrent aphthous stomatitis and smoking: an epidemiological study measuring plasma cotinice. Oral Dis. 2002;8:173-6.
33. Barnadas MA, Remacha A, Condomines J, De Moragas JM. Estudio de los déficits hematológicos en los enfermos afectados de aftas orales recidivantes. Med Clin (Barc). 1997;109:85-7.
34. Ogura M, Yamamoto T, Morita M, Watanabe T. A case-control study on food intake of patients with recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:45-9.
35. Esparza Gómez G. Tratamiento de las aftas. Med Oral. 2003;8:383.
36. Gordon JN, Goggin PM. Thalidomide and its derivates: emerging from the wilderness. Postgrad Med J. 2003;79:127-32.
37. Hegarty A, Hodgson T, Porter S. Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:576-85.
38. Pizarro A, Herranz P, García-Tobaruelaa A, Casado M. Pentoxifilina en el tratamiento de la aftosis orogenital y del síndrome de Behçet. Med Clin (Barc). 2000;115:678.
39. Santos J, Marquez M, Rivero A, Salgado F. Pentoxifilina en pacientes con sida y aftas orales. Med Clin (Barc). 1994;102:519.
40. Pizarro A, Herranz P, Ferre M, Casado M. Aftosis oral recurrente: tratamiento con pentoxifilina. Med Clin (Barc). 1993;101:237.
41. Tercedor J, Ortego N, Ródenas JM, Hernández J. Tratamiento de las aftas recurrentes con talidomida en pacientes con sindrome de inmunodeficiencia adquirida. Med Clin (Barc). 1991;97:79.
42. MacPhail L, Greenspan D. Herpetic gingivostomatitis in a 70-year-old man. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:50-2.
43. Gandara JM, Pacheco JL, Gándara P, Blanco A, García A. Gingivoestomatitis herpética primaria en un paciente de 65 años. Med Oral. 2002;7:180-3.
44. Woo SB, Lee SF, Mass B. Oral recrudescent herpes simplex virus infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:239-43.
45. Bascones A, Serrano C, Campo J. Manifestaciones del virus de la inmunodeficiencia humana en la cavidad bucal. Med Clin (Barc). 2003;120;426-34.
46. Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ. Changing prevalence of oral manifestations of human immunodeficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89:299-304.
47. Williams DM, Leigh J, Ramírez-Amador V, Kaonga K, Russo D, Schidt M. Host pathogen interaction and the development of oral lesions Oral Dis 2002;8 Suppl 2:120-5.
48. Eyeson JD, Warnakulasuriya K, Johnson NW. Prevalence and incidence of oral lesions- the changing scene. Oral Dis. 2000;6:267-73.
49. Rowland RW. Necrotizing ulcerative gingivitis. Ann Periodontol. 1999;4:65-73.
50. Schneider LC, Schneider AE. Dianosis of oral ulcers. Mt Sinai J Med. 1998;65:383-7.
51. Femopase FL, Hernández SL, Gendelman H, Criscuolo MI, López de Blanc SA. Sialometaplasia necrosante: presentación de cinco casos clínicos. Med Oral. 2004;9:304-8.
52. Imbery TA, Edwards PA. Necrotizing sialometaplasia: literature review and case reports. JADA. 1996;127:1087-92.
53. Quart A, Butkus C, Klein R. The cocaine connection. Users imperil their gingiva. JADA. 1991;122:85-7.
54. Mitchell-Lewis DA, Phelan JA, Kelly RB, Bradley JJ, Lamster IB. Identifying oral lesions associated with crack cocaine use. JADA. 1994;125:1104-8.
55. Bermejo-Fenoll A, López-Jornet P. Liquen piano oral. Naturaleza, aspectos clínicos y tratamiento. RCOE. 2004;9:395-408.
56. Cerero Lapiedra R, Moreno López LA. Liquen piano oral. Gaceta Dental. 2000;104:22-6.
57. García-Pola Vallejo MJ, Huerta G, Cerero R, Seoane JM. Anxiety and depression as risk factors for oral lichen planus. Dermatology. 2001;203:303-7.
58. Niisalo S, Hietanen J, Malmström M, Hukkanen M, Polak J, Konttinen YT. Disorder-specific changes in innervation in oral lichen planus and lichenoid reactions. J Oral Pathol Med. 2000;29:361-9.
59. Niisalo S, Hampf G, Hietanen J, Malmström M, Solovieva S, Pertovaara A, et al. Thermal sensation and pain in oral lichen planus and lichenoid reactions. J Oral Pathol Med. 2003;32:41-5.
60. Villaroel M, Correnti M, Delgado R, Tapia FJ. Oral lichen planus: immunohistology of mucosal lesions. J Oral Pathol Med. 2002;31:410-4.
61. Epstein JB, Wan LS, Gorsky M, Zhang L. Oral lichen planus: progress in understanding its malignant potential and the implications for clinical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:32-7.
62. Camps Ragá M, Bagán Sebastián JV, Ramón Fluixá C, Gavaldá Esteve C. Asociación entre el liquen plano oral y carcinoma oral de células escamosas. Presentación de seis casos. Revista Europea de Odonto-Estomatologia. 1999;11:219-26.
63. Lanfranchi HE, Aguas SC, Sano SM. Transformación maligna del liquen bucal atipico: análisis de 32 casos. Med Oral. 2003;8:2-9.
64. Markopoulus AK, Antoniades D, Papanayotou P, Trigonadis G. Malignant potential of oral lichen planus: a follow-up study of 326 patients. Oral Oncology. 1997;33:263-9.
65. Van der Meij E, Shepman K, Van der Waal I. The possible premalignant character of oral lichenoid lesions: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:164-71.
66. Abdollahi M, Radfar M. A review of drug-induced oral reactions. J Contemp Dent Pract. 2003;41:10-31.
67. Shotts RH, Scully C. Nicorandil-induced severe oral ulceration. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;87:706-7.
68. Scully C, Mano A, Crighton A, Felix D, Field A, Porter SR. Nicorandil can induce severe oral ulceration. Oral Surg Oral Med Ora Pathol Oral Radiol Endod. 2001;91:189-93.
69. Cohen DM, Bhattacharyya I. Recalcitrant oral ulcers caused by calcium channel blockers: diagnosis and treatment considerations. JADA. 1999;130:1611-8
70. Demerjian N, Bolla G, Spreux A. Severe oral ulcerations induced by alendronate. Clin Rheumatol. 1999;18:349-50.
71. González-Moles MA, Bagán Sebastián JV. Alendronate-related oral mucosa ulcerations. J Oral Pathol Med. 2000;29:514-8.
72. Krasagakis K, Krüger-Krasagakis S, Ioannidou D, Tosca A. Chronic erosive and ulcerative oral lesions caused by incorrect administration of alendronate. J Am Acad Dermatol. 2004;50:651-2.
73. Courrier B, Plantier F, Küffer R. Ulcerated mass of the retromolar area. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:635-9.
74. Scully C, Carrozzo M, Gandolfo S, Puiatti P, Monteil R. Update on mucous membrane pemphigoid. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:56-68.
75. Chan LS, Ahmed R, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, et al. The first international consensus on mucous membrane pemphigoid. Arch Dermatol. 2002;138:370-9.
76. Milán-Masanet MA, Sanchis-Bielsa JM. Penfigoides: revisión y puesta al día. RCOE. 2004;9:429-34.
77. Parisi E, Raghavendra S, Werth V, Sollecito TP. Modification to the approach of the diagnosis of mucous membrane pemphigoid: a case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:182-6.
78. Dayan S, Simmons RK, Ahmed A. Contemporary issues in the diagnosis of oral pemphigoid. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:424-30.
79. Egan CA, Lazarova Z, Darling TN, Yee C, Coté T, Yancey KB. Anti-epiligirn cicatricial pemphigoid and relative risk for cancer. Lancet. 2001;357:1850-1.
80. Jiménez-Soriano Y, Díaz-Fernández JM. Enfermedades ampollares en la cavidad oral: pénfigo. RCOE. 2004;939-47.
81. Allen CM, Camisa C. Paraneoplastic pemphigus: a review of the literature. Oral Dis. 2000;6:208-14.